BFA
HPTX

BlackRock Fund Advisors’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

BlackRock Fund Advisors’s Portfolio HPTX Stock Details HPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-638,959
Closed -$29.3M – 3984
2015
Q1 		$29.3M Buy
638,959
+14,999
+2% +$449K 0.01% 1852
2014
Q4 		$15M Buy
623,960
+299,968
+93% +$6.76M ﹤0.01% 2231
2014
Q3 		$8.17M Sell
323,992
-11,142
-3% -$277K ﹤0.01% 2471
2014
Q2 		$8.75M Buy
335,134
+99,784
+42% +$2.57M ﹤0.01% 2503
2014
Q1 		$6.07M Buy
235,350
+7,888
+3% +$214K ﹤0.01% 2702
2013
Q4 		$4.6M Sell
227,462
-229,741
-50% -$5.41M ﹤0.01% 2879
2013
Q3 		$11.9M Buy
457,203
+59,982
+15% +$1.5M ﹤0.01% 2247
2013
Q2 		$8.74M Buy
+397,221
New +$8.7M ﹤0.01% 2331

BlackRock Fund Advisors's HPTX Position: Q2 2015 in Review

BlackRock Fund Advisors sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 638,959 shares — an estimated $29.3M sold.

BlackRock Fund Advisors first reported a position in HPTX in Q2 2013 and held it in 8 quarters. The position peaked at $29.3M in Q1 2015. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

  • BlackRock Fund Advisors reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • BlackRock Fund Advisors sold 638,959 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $29.3M.
  • BlackRock Fund Advisors first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 8 quarters.
  • BlackRock Fund Advisors's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $29.3M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on BlackRock Fund Advisors's 13F filing for Q2 2015, filed 7 Aug 2015.